Answers are grounded in this paper and cite their sources.
The ability to precisely functionalize individual C-H bonds in complex organic molecules would transform synthetic strategies to produce essential chemicals. In nature, C-H oxidations are commonly achieved using metalloenzymes such as cytochrome P450s, however adapting these systems to achieve selective conversions of complex substrates requires extensive enzyme discovery and engineering campaigns. Here we show that selective C-H oxidation biocatalysts can be programmed computationally from minimal structural inputs comprising a Cys-ligated heme cofactor, catalytic side chains required for H 2 O 2 activation and heterolysis, and the target substrate precisely positioned adjacent to the resulting ferryl intermediate (Compound I). We designed heme hydroxylases for increasingly complex substrates, progressing from aromatic and aliphatic oxidations of fluorogenic model compounds to regiodivergent oxidation of estradiol at either the benzylic C6 (93% d.e.) or unactivated C16 (99% d.e.) positions. Crystal structures across all campaigns confirm the accuracy of the design pipeline. Together, these results establish a general framework for constructing selective heme hydroxylases around predefined substrates and reaction geometries, providing a path toward custom biocatalysts for site-selective C-H functionalizations.
No takes yet. Share an insight, caveat, or question.
Kalvet et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: